| |
Group 1
<1.2 mg/dL
n=63 |
Group 2
1.2-2.3 mg/dL
n=64 |
Group 3
≥ 2.3 mg/dL
n=64 |
p - Value |
| Age (years) |
67.8 ± 9.1 |
62.2 ± 9.4 |
59.3 ± 10.2 a,b |
<0.001 |
| BMI (kg/m2) |
24.3 ± 2.2 |
27.1 ± 6.0 |
26.2 ± 4.2a |
0.007 |
| Hb (g/dL) |
12.0 ± 1.8 |
12.6 ± 1.8 |
12.9 ± 2.0a |
0.041 |
| Albumin (g/dL) |
3.8 ± 0.6 |
4.2 ± 0.7a |
4.3 ± 0.4a |
<0.001 |
| Total Cholesterol (mg/dL) |
191.7 ± 44.7 |
188.3 ± 32.9 |
190.9 ± 40.5 |
0.881 |
| Creatinine (mg/dL) |
2.6 ± 0.9 |
2.0 ± 0.9a |
1.7 ± 0.9a |
<0.001 |
| eGFR (mL/min) |
25.5 ± 12.2 |
41.3 ± 22.0a |
51.8 ± 23.8a,b |
<0.001 |
| Phosphorus (mg/dL) |
5.5 ± 1.6 |
4.4 ± 0.8a |
3.7 ± 0.7a,b |
<0.001 |
| PTH (pg/mL) |
257.3 ± 127.0 |
141.8 ± 83.5a |
69.1 ± 36.8a,b |
<0.001 |
| Calcium (mg/dL) |
9.4 ± 0.8 |
9.5 ± 0.9 |
9.4 ± 0.8 |
0.853 |
| FGF-23 (RU/mL) |
484.1 ± 208.9 |
142.4 ± 87.6a |
55.3 ± 11.2a,b |
<0.001 |
| 1,25(OH)2D3
(pg/mL) |
9.5 ± 1.8 |
17.6 ± 7a |
26.2 ± 3.4a,b |
<0.001 |
| HOMA-IR |
3.7 ± 0.9 |
2.7 ± 1.9a |
0.9 ± 1.0a,b |
<0.001 |
| IL-6 (pg/mL) |
2.8 ± 0.4 |
2.6 ± 0.7 |
1.7 ± 0.7a,b |
<0.001 |
| OxLDL (U/L) |
76.6 ± 14.2 |
47.9 ± 17.4a |
27.7 ± 5.4a,b |
<0.001 |
| PP (mmHg) |
74.3 ± 12.1 |
47.6 ± 5.3 |
38.0 ± 9.6 a,b |
0.002 |
| LVMI (g/m2) |
133.2 ± 18.4 |
109.5 ± 23.0a |
86.9 ± 13.8a,b |
<0.001 |
| IMT |
1.2 ± 0.2 |
1.03 ± 0.2 |
0.79 ± 0.7 a,b |
<0.001 |
| Hospitalization days |
12.4 ± 8.7 |
10.2 ± 16.5 |
1.8 ± 6.8 a,b |
<0.001 |
Results of post-hoc analysis: ap<0.05 vs. Group 1, b p<0.05 vs. Group 2 |
